Advertisement

Taking Action

Advocacy

  • Policy Matters

    A Call to Eliminate Inequities

    The AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.

    by Lisa A. Newman, MD, MPH

  • Cultural Competence in the Community

    Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.

    by Kevin McLaughlin

  • Working Toward the End of Cancer Health Disparities

    AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.

    by Eric Fitzsimmons

  • Policy Matters

    A Groundbreaking Report on COVID-19 and Cancer

    The report released by the American Association for Cancer Research includes a Call to Action that offers a roadmap for policymakers to better prepare and respond to the next pandemic.

    by Antoni Ribas, MD, PhD

  • Policy Matters

    Patient Advocacy Is Driving Change

    Patient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.

    by Carrie Treadwell, MBA

  • Forward Look

    Going Flat

    Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

    by Kris Conner

  • Survivor Profile

    Breaking Down Barriers

    Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.

    by Bradley Jones

  • The Individual Sphere of Influence

    Can discussion of health inequities lead to actionable change?

    by Marci A. Landsmann

  • Hope for Cancer Health Equity

    Health care providers and communities are making strides toward ensuring equity in cancer treatment.

    by Marci A. Landsmann

  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami